Cargando…
Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020
BACKGROUND: Very few studies describe factors associated with COVID-19 diagnosis in children. AIM: We here describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 paediatric centres across Italy. METHODS: We included cases aged 0–18 years tested between 23 February...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034058/ https://www.ncbi.nlm.nih.gov/pubmed/33834960 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.14.2001248 |
_version_ | 1783676473205325824 |
---|---|
author | Lazzerini, Marzia Sforzi, Idanna Trapani, Sandra Biban, Paolo Silvagni, Davide Villa, Giovanna Tibaldi, Jessica Bertacca, Luca Felici, Enrico Perricone, Giuseppina Parrino, Roberta Gioè, Claudia Lega, Sara Conte, Mariasole Marchetti, Federico Magista, Annamaria Berlese, Paola Martelossi, Stefano Vaienti, Francesca Valletta, Enrico Mauro, Margherita Dall’Amico, Roberto Fasoli, Silvia Gatto, Antonio Chiaretti, Antonio Dragovic, Danica Pascolo, Paola Pilotto, Chiara Liguoro, Ilaria Miorin, Elisabetta Saretta, Francesca Trobia, Gian Luca Di Stefano, Antonella Orlandi, Azzurra Cardinale, Fabio Lubrano, Riccardo Testa, Alessia Binotti, Marco Moressa, Valentina Barbi, Egidio Armocida, Benedetta Mariani, Ilaria |
author_facet | Lazzerini, Marzia Sforzi, Idanna Trapani, Sandra Biban, Paolo Silvagni, Davide Villa, Giovanna Tibaldi, Jessica Bertacca, Luca Felici, Enrico Perricone, Giuseppina Parrino, Roberta Gioè, Claudia Lega, Sara Conte, Mariasole Marchetti, Federico Magista, Annamaria Berlese, Paola Martelossi, Stefano Vaienti, Francesca Valletta, Enrico Mauro, Margherita Dall’Amico, Roberto Fasoli, Silvia Gatto, Antonio Chiaretti, Antonio Dragovic, Danica Pascolo, Paola Pilotto, Chiara Liguoro, Ilaria Miorin, Elisabetta Saretta, Francesca Trobia, Gian Luca Di Stefano, Antonella Orlandi, Azzurra Cardinale, Fabio Lubrano, Riccardo Testa, Alessia Binotti, Marco Moressa, Valentina Barbi, Egidio Armocida, Benedetta Mariani, Ilaria |
author_sort | Lazzerini, Marzia |
collection | PubMed |
description | BACKGROUND: Very few studies describe factors associated with COVID-19 diagnosis in children. AIM: We here describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 paediatric centres across Italy. METHODS: We included cases aged 0–18 years tested between 23 February and 24 May 2020. Our primary analysis focused on children tested because of symptoms/signs suggestive of COVID-19. RESULTS: Among 2,494 children tested, 2,148 (86.1%) had symptoms suggestive of COVID-19. Clinical presentation of confirmed COVID-19 cases included besides fever (82.4%) and respiratory signs or symptoms (60.4%) also gastrointestinal (18.2%), neurological (18.9%), cutaneous (3.8%) and other unspecific influenza-like presentations (17.8%). In multivariate analysis, factors significantly associated with SARS-CoV-2 positivity were: exposure history (adjusted odds ratio (AOR): 39.83; 95% confidence interval (CI): 17.52–90.55; p < 0.0001), cardiac disease (AOR: 3.10; 95% CI: 1.19–5.02; p < 0.0001), fever (AOR: 3.05%; 95% CI: 1.67–5.58; p = 0.0003) and anosmia/ageusia (AOR: 4.08; 95% CI: 1.69–9.84; p = 0.002). Among 190 (7.6%) children positive for SARS-CoV-2, only four (2.1%) required respiratory support and two (1.1%) were admitted to intensive care; all recovered. CONCLUSION: Recommendations for SARS-CoV-2 testing in children should consider the evidence of broader clinical features. Exposure history, fever and anosmia/ageusia are strong risk factors in children for positive SARS-CoV-2 testing, while other symptoms did not help discriminate positive from negative individuals. This study confirms that COVID-19 was a mild disease in the general paediatric population in Italy. Further studies are needed to understand risk, clinical spectrum and outcomes of COVID-19 in children with pre-existing conditions. |
format | Online Article Text |
id | pubmed-8034058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-80340582021-04-12 Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 Lazzerini, Marzia Sforzi, Idanna Trapani, Sandra Biban, Paolo Silvagni, Davide Villa, Giovanna Tibaldi, Jessica Bertacca, Luca Felici, Enrico Perricone, Giuseppina Parrino, Roberta Gioè, Claudia Lega, Sara Conte, Mariasole Marchetti, Federico Magista, Annamaria Berlese, Paola Martelossi, Stefano Vaienti, Francesca Valletta, Enrico Mauro, Margherita Dall’Amico, Roberto Fasoli, Silvia Gatto, Antonio Chiaretti, Antonio Dragovic, Danica Pascolo, Paola Pilotto, Chiara Liguoro, Ilaria Miorin, Elisabetta Saretta, Francesca Trobia, Gian Luca Di Stefano, Antonella Orlandi, Azzurra Cardinale, Fabio Lubrano, Riccardo Testa, Alessia Binotti, Marco Moressa, Valentina Barbi, Egidio Armocida, Benedetta Mariani, Ilaria Euro Surveill Research BACKGROUND: Very few studies describe factors associated with COVID-19 diagnosis in children. AIM: We here describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 paediatric centres across Italy. METHODS: We included cases aged 0–18 years tested between 23 February and 24 May 2020. Our primary analysis focused on children tested because of symptoms/signs suggestive of COVID-19. RESULTS: Among 2,494 children tested, 2,148 (86.1%) had symptoms suggestive of COVID-19. Clinical presentation of confirmed COVID-19 cases included besides fever (82.4%) and respiratory signs or symptoms (60.4%) also gastrointestinal (18.2%), neurological (18.9%), cutaneous (3.8%) and other unspecific influenza-like presentations (17.8%). In multivariate analysis, factors significantly associated with SARS-CoV-2 positivity were: exposure history (adjusted odds ratio (AOR): 39.83; 95% confidence interval (CI): 17.52–90.55; p < 0.0001), cardiac disease (AOR: 3.10; 95% CI: 1.19–5.02; p < 0.0001), fever (AOR: 3.05%; 95% CI: 1.67–5.58; p = 0.0003) and anosmia/ageusia (AOR: 4.08; 95% CI: 1.69–9.84; p = 0.002). Among 190 (7.6%) children positive for SARS-CoV-2, only four (2.1%) required respiratory support and two (1.1%) were admitted to intensive care; all recovered. CONCLUSION: Recommendations for SARS-CoV-2 testing in children should consider the evidence of broader clinical features. Exposure history, fever and anosmia/ageusia are strong risk factors in children for positive SARS-CoV-2 testing, while other symptoms did not help discriminate positive from negative individuals. This study confirms that COVID-19 was a mild disease in the general paediatric population in Italy. Further studies are needed to understand risk, clinical spectrum and outcomes of COVID-19 in children with pre-existing conditions. European Centre for Disease Prevention and Control (ECDC) 2021-04-08 /pmc/articles/PMC8034058/ /pubmed/33834960 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.14.2001248 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Research Lazzerini, Marzia Sforzi, Idanna Trapani, Sandra Biban, Paolo Silvagni, Davide Villa, Giovanna Tibaldi, Jessica Bertacca, Luca Felici, Enrico Perricone, Giuseppina Parrino, Roberta Gioè, Claudia Lega, Sara Conte, Mariasole Marchetti, Federico Magista, Annamaria Berlese, Paola Martelossi, Stefano Vaienti, Francesca Valletta, Enrico Mauro, Margherita Dall’Amico, Roberto Fasoli, Silvia Gatto, Antonio Chiaretti, Antonio Dragovic, Danica Pascolo, Paola Pilotto, Chiara Liguoro, Ilaria Miorin, Elisabetta Saretta, Francesca Trobia, Gian Luca Di Stefano, Antonella Orlandi, Azzurra Cardinale, Fabio Lubrano, Riccardo Testa, Alessia Binotti, Marco Moressa, Valentina Barbi, Egidio Armocida, Benedetta Mariani, Ilaria Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 |
title | Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 |
title_full | Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 |
title_fullStr | Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 |
title_full_unstemmed | Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 |
title_short | Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 |
title_sort | characteristics and risk factors for sars-cov-2 in children tested in the early phase of the pandemic: a cross-sectional study, italy, 23 february to 24 may 2020 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034058/ https://www.ncbi.nlm.nih.gov/pubmed/33834960 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.14.2001248 |
work_keys_str_mv | AT lazzerinimarzia characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT sforziidanna characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT trapanisandra characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT bibanpaolo characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT silvagnidavide characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT villagiovanna characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT tibaldijessica characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT bertaccaluca characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT felicienrico characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT perriconegiuseppina characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT parrinoroberta characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT gioeclaudia characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT legasara characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT contemariasole characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT marchettifederico characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT magistaannamaria characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT berlesepaola characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT martelossistefano characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT vaientifrancesca characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT vallettaenrico characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT mauromargherita characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT dallamicoroberto characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT fasolisilvia characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT gattoantonio characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT chiarettiantonio characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT dragovicdanica characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT pascolopaola characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT pilottochiara characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT liguoroilaria characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT miorinelisabetta characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT sarettafrancesca characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT trobiagianluca characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT distefanoantonella characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT orlandiazzurra characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT cardinalefabio characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT lubranoriccardo characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT testaalessia characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT binottimarco characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT moressavalentina characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT barbiegidio characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT armocidabenedetta characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT marianiilaria characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 AT characteristicsandriskfactorsforsarscov2inchildrentestedintheearlyphaseofthepandemicacrosssectionalstudyitaly23februaryto24may2020 |